Guillermo Valenzuela - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Guillermo Valenzuela

Showing results (31-40 of 36) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 36 results.

The New England Journal of Medicine|October 5, 2022

Trial of Intravenous Immune Globulin in DermatomyositisRohit Aggarwal, Christina Charles-Schoeman, Joachim Schessl, et al.

Cancers|August 7, 2019

Coagulation Factor Xa Promotes Solid Tumor Growth, Experimental Metastasis and Endothelial Cell ActivationMaximiliano Arce, Mauricio P Pinto, Macarena Galleguillos, et al.

Scientific Reports|February 9, 2021

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobodyGuillermo Valenzuela Nieto, Ronald Jara, Daniel Watterson, et al.

Nature Aging|November 13, 2023

Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathologyJulio Aguado, Alberto A Amarilla, Atefeh Taherian Fard, et al.

Nature Structural & Molecular Biology|July 8, 2025

A nanobody-based therapeutic targeting Nipah virus limits viral escapeAriel Isaacs, Guillermo Valenzuela Nieto, Xinghai Zhang, et al.

Iscience|June 26, 2023

A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variantsNaphak Modhiran, Simon Malte Lauer, Alberto A Amarilla, et al.

Pageof 4

Search research articles

Showing results (31-40 of 36) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 36 results.

The New England Journal of Medicine|October 5, 2022

Trial of Intravenous Immune Globulin in DermatomyositisRohit Aggarwal, Christina Charles-Schoeman, Joachim Schessl, et al.

Cancers|August 7, 2019

Coagulation Factor Xa Promotes Solid Tumor Growth, Experimental Metastasis and Endothelial Cell ActivationMaximiliano Arce, Mauricio P Pinto, Macarena Galleguillos, et al.

Scientific Reports|February 9, 2021

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobodyGuillermo Valenzuela Nieto, Ronald Jara, Daniel Watterson, et al.

Nature Aging|November 13, 2023

Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathologyJulio Aguado, Alberto A Amarilla, Atefeh Taherian Fard, et al.

Nature Structural & Molecular Biology|July 8, 2025

A nanobody-based therapeutic targeting Nipah virus limits viral escapeAriel Isaacs, Guillermo Valenzuela Nieto, Xinghai Zhang, et al.

Iscience|June 26, 2023

A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variantsNaphak Modhiran, Simon Malte Lauer, Alberto A Amarilla, et al.

Pageof 4